MAIA Biotechnology, Inc. is a targeted therapy, immune-oncology company, focused on development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer.
Nasdaq Down 50 Points; US Home Price Index Rises In FebruaryApr 25, 2023Benzinga
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping around 50 points on Tuesday.
Following the market opening Tuesday, the Dow traded...